Sugata K, Yasunaga J, Mitobe Y, Miura M, Miyazato P, Kohara M, Matsuoka M.

Protective effect of cytotoxic T lymphocytes targeting HTLV-1 bZIP factor.

Blood. 2015 Aug 27;126(9):1095-105. doi: 10.1182/blood-2015-04-641118. Epub 2015 Jun 10. PMID: 26063164.

https://pubmed.ncbi.nlm.nih.gov/26063164/

Mitagami Y, Yasunaga J, Kinosada H, Ohshima K, Matsuoka M.

Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.

PLoS Pathog. 2015 Aug 21;11(8):e1005120. doi: 10.1371/journal.ppat.1005120. Erratum in: PLoS Pathog. 2015 Oct;11(10):e1005214. PMID: 26296091; PMCID: PMC4546626.

https://pubmed.ncbi.nlm.nih.gov/26296091/

Ghosh AK, Yu X, Osswald HL, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H.

Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies.

J Med Chem. 2015 Jul 9;58(13):5334-43. doi: 10.1021/acs.jmedchem.5b00676. Epub 2015 Jun 24. PMID: 26107245; PMCID: PMC4765733.

https://pubmed.ncbi.nlm.nih.gov/26107245/

Kinpara S, Ito S, Takahata T, Saitoh Y, Hasegawa A, Kijiyama M, Utsunomiya A, Masuda M, Miyazaki Y, Matsuoka M, Nakamura M, Yamaoka S, Masuda T, Kannagi M.

Involvement of double-stranded RNA-dependent protein kinase and antisense viral RNA in the constitutive NFκB activation in adult T-cell leukemia/lymphoma cells.

Leukemia. 2015 Jun;29(6):1425-9. doi: 10.1038/leu.2015.1. Epub 2014 Jan 8. PMID: 25567137.

https://pubmed.ncbi.nlm.nih.gov/25567137/

Suehiro Y, Hasegawa A, Iino T, Sasada A, Watanabe N, Matsuoka M, Takamori A, Tanosaki R, Utsunomiya A, Choi I, Fukuda T, Miura O, Takaishi S, Teshima T, Akashi K, Kannagi M, Uike N, Okamura J.

Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.

Br J Haematol. 2015 May;169(3):356-67. doi: 10.1111/bjh.13302. Epub 2015 Jan 22. PMID: 25612920.

https://pubmed.ncbi.nlm.nih.gov/25612920/

Amano M, Tojo Y, Salcedo-Gómez PM, Parham GL, Nyalapatla PR, Das D, Ghosh AK, Mitsuya H.

A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro.

Antimicrob Agents Chemother. 2015 May;59(5):2625-35. doi: 10.1128/AAC.04757-14. Epub 2015 Feb 17. PMID: 25691652; PMCID: PMC4394833.

https://pubmed.ncbi.nlm.nih.gov/25691652/

Okazaki S, Oishi S, Mizuhara T, Shimura K, Murayama H, Ohno H, Matsuoka M, Fujii N.

Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds.

Org Biomol Chem. 2015 Apr 28;13(16):4706-13. doi: 10.1039/c5ob00301f. PMID: 25800792.

https://pubmed.ncbi.nlm.nih.gov/25800792/

Fujiwara S, Wada N, Kawano Y, Okuno Y, Kikukawa Y, Endo S, Nishimura N, Ueno N, Mitsuya H, Hata H.

Lactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1.

Exp Hematol Oncol. 2015 Apr 21;4:12. doi: 10.1186/s40164-015-0008-z. PMID: 25909034; PMCID: PMC4407384.

https://pubmed.ncbi.nlm.nih.gov/25909034/

Furuta RA, Ma G, Matsuoka M, Otani S, Matsukura H, Hirayama F.

Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.

Transfusion. 2015 Apr;55(4):880-9. doi: 10.1111/trf.12911. Epub 2014 Nov 2. PMID: 25363675.

https://pubmed.ncbi.nlm.nih.gov/25363675/

Okazaki S, Mizuhara T, Shimura K, Murayama H, Ohno H, Oishi S, Matsuoka M, Fujii N.

Identification of anti-HIV agents with a novel benzo[4,5]isothiazolo[2,3-a]pyrimidine scaffold.

Bioorg Med Chem. 2015 Apr 1;23(7):1447-52. doi: 10.1016/j.bmc.2015.02.015. Epub 2015 Feb 16. PMID: 25744188.

https://pubmed.ncbi.nlm.nih.gov/25744188/

Takachi T, Takahashi M, Takahashi-Yoshita M, Higuchi M, Obata M, Mishima Y, Okuda S, Tanaka Y, Matsuoka M, Saitoh A, Green PL, Fujii M.

Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.

Cancer Sci. 2015 Apr;106(4):461-5. doi: 10.1111/cas.12618. Epub 2015 Mar 16. PMID: 25613934; PMCID: PMC4409891.

https://pubmed.ncbi.nlm.nih.gov/25613934/

Das D, Maeda K, Hayashi Y, Gavande N, Desai DV, Chang SB, Ghosh AK, Mitsuya H.

Insights into the mechanism of inhibition of CXCR4: identification of Piperidinylethanamine analogs as anti-HIV-1 inhibitors.

Antimicrob Agents Chemother. 2015 Apr;59(4):1895-904. doi: 10.1128/AAC.04654-14. Epub 2015 Jan 12. PMID: 25583709; PMCID: PMC4356787.

https://pubmed.ncbi.nlm.nih.gov/25583709/

Wada N, Kawano Y, Fujiwara S, Kikukawa Y, Okuno Y, Tasaki M, Ueda M, Ando Y, Yoshinaga K, Ri M, Iida S, Nakashima T, Shiotsu Y, Mitsuya H, Hata H.

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.

Int J Oncol. 2015 Mar;46(3):963-72. doi: 10.3892/ijo.2014.2804. Epub 2014 Dec 19. PMID: 25530098; PMCID: PMC4324584.

https://pubmed.ncbi.nlm.nih.gov/25530098/

Haji S, Abe Y, Tsuda M, Toyoda K, Choi I, Suehiro Y, Shiratsuchi M, Kiyasu J, Uike N.

[CD20-positive plasma cell myeloma with lymphoplasmacytoid appearance mimicking low-grade B-cell lymphoma].

Rinsho Ketsueki. 2015 Mar;56(3):335-8. Japanese. doi: 10.11406/rinketsu.56.335. PMID: 25876789.

https://pubmed.ncbi.nlm.nih.gov/25876789/

Ma G, Yasunaga J, Akari H, Matsuoka M.

TCF1 and LEF1 act as T-cell intrinsic HTLV-1 antagonists by targeting Tax.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2216-21. doi: 10.1073/pnas.1419198112. Epub 2015 Feb 2. PMID: 25646419; PMCID: PMC4343127.

https://pubmed.ncbi.nlm.nih.gov/25646419/

Kikukawa Y, Yuki H, Hirata S, Ide K, Nakata H, Miyakawa T, Matsuno N, Nosaka K, Yonemura Y, Kawaguchi T, Hata H, Mitsuya H, Okuno Y.

Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study.

Int J Hematol. 2015 Feb;101(2):133-9. doi: 10.1007/s12185-014-1705-9. Epub 2014 Nov 28. PMID: 25430082.

https://pubmed.ncbi.nlm.nih.gov/25430082/

Ghosh AK, Yashchuk S, Mizuno A, Chakraborty N, Agniswamy J, Wang YF, Aoki M, Gomez PM, Amano M, Weber IT, Mitsuya H.

Design of gem-difluoro-bis-tetrahydrofuran as P2 ligand for HIV-1 protease inhibitors to improve brain penetration: synthesis, X-ray studies, and biological evaluation.

ChemMedChem. 2015 Jan;10(1):107-15. doi: 10.1002/cmdc.201402358. Epub 2014 Oct 21. PMID: 25336073; PMCID: PMC4419590.

https://pubmed.ncbi.nlm.nih.gov/25336073/

Kikukawa Y, Yamamura-Fujimoto A, Endo S, Miyagawa E, Kawano Y, Ueno S, Mitsuya H, Hata H, Okuno Y.

Successful Treatment of Bing-Neel Syndrome Accompanying Waldenström’s Macroglobulinemia with R-MPV: A Case Report.

J Clin Exp Hematop. 2015;55(2):113-9. doi: 10.3960/jslrt.55.113. PMID: 26490525.

https://pubmed.ncbi.nlm.nih.gov/26490525/

Hirano T, Higuchi Y, Yuki H, Hirata S, Nosaka K, Ishii N, Hashimoto T, Mitsuya H, Okuno Y.

Rituximab Monotherapy and Rituximab-Containing Chemotherapy Were Effective for Paraneoplastic Pemphigus Accompanying Follicular Lymphoma, but not for Subsequent Bronchiolitis Obliterans.

J Clin Exp Hematop. 2015;55(2):83-8. doi: 10.3960/jslrt.55.83. PMID: 26490520.

https://pubmed.ncbi.nlm.nih.gov/26490520/

Imoto S, Kohgo S, Tokuda R, Kumamoto H, Aoki M, Amano M, Kuwata-Higashi N, Mitsuya H, Haraguchi K.

Design, Synthesis, and Evaluation of Anti-HBV Activity of Hybrid Molecules of Entecavir and Adefovir: Exomethylene Acycloguanine Nucleosides and Their Monophosphate Derivatives.

Nucleosides Nucleotides Nucleic Acids. 2015;34(8):590-602. doi: 10.1080/15257770.2015.1037456. PMID: 26167667.

https://pubmed.ncbi.nlm.nih.gov/26167667/

Miyazaki Y, Taguchi K, Sou K, Watanabe H, Ishima Y, Miyakawa T, Mitsuya H, Fukagawa M, Otagiri M, Maruyama T.

Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemia.

Mol Pharm. 2014 Nov 3;11(11):4238-48. doi: 10.1021/mp500453a. Epub 2014 Oct 6. PMID: 25255196.

https://pubmed.ncbi.nlm.nih.gov/25255196/

Lavorgna A, Matsuoka M, Harhaj EW.

A critical role for IL-17RB signaling in HTLV-1 tax-induced NF-κB activation and T-cell transformation.

PLoS Pathog. 2014 Oct 23;10(10):e1004418. doi: 10.1371/journal.ppat.1004418. PMID: 25340344; PMCID: PMC4207800.

https://pubmed.ncbi.nlm.nih.gov/25340344/

Uike N, Choi I, Tsuda M, Haji S, Toyoda K, Suehiro Y, Abe Y, Hayashi T, Sawamoto H, Kaneko K, Shimokawa M, Nakagawa M.

Factors associated with effects of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory low-grade B cell non-Hodgkin lymphoma: single-institution experience with 94 Japanese patients in rituximab era.

Int J Hematol. 2014 Oct;100(4):386-92. doi: 10.1007/s12185-014-1636-5. Epub 2014 Aug 21. PMID: 25142378.

https://pubmed.ncbi.nlm.nih.gov/25142378/

Niederer HA, Laydon DJ, Melamed A, Elemans M, Asquith B, Matsuoka M, Bangham CR.

HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP.

Virol J. 2014 Sep 30;11:172. doi: 10.1186/1743-422X-11-172. PMID: 25270762; PMCID: PMC4192323.

https://pubmed.ncbi.nlm.nih.gov/25270762/